Zimmer Holdings says the SEC and the U.S. Justice Dept. closed a probe into possible violations of the Foreign Corrupt Practices Act by the orthopedic medical device company.
A federal probe into possible violations of the Foreign Corrupt Practices Act by Zimmer (NYSE:ZMH) is over, with both the SEC and the U.S. Justice Dept. telling the medical device company that they’re closing the investigation.
The probe dates back to September 2007, when the securities regulator told Warsaw, Ind.- based Zimmer of the investigation. A month later the Justice Dept. requested a copy of all materials sent to the SEC, and by the 1st quarter of 2011 the SEC was issuing subpoenas for documents on Zimmer’s Asia Pacific operations, according to a regulatory filing.